Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Guided Therapeutics stock (Guided Therapeutics)

Learn how to buy Guided Therapeutics stock in 5 easy steps.

Guided Therapeutics is conducting an offering of units comprised of one share and one warrant exercisable for one share. The deal is contingent upon the approval of its application for listing on the Nasdaq.

The company's stock is currently traded on the Over-the-Counter Markets.

We'll update this page as new information becomes available.

Our top picks for where to buy Guided Therapeutics stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $1,000 in stock
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy Guided Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – GTHP. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Guided Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $1,000 in stock
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Guided Therapeutics stock price (OTCQB: GTHP)

Use our graph to track the performance of GTHP stocks over time.

Guided Therapeutics shares at a glance

Information last updated 2024-07-06.
Latest market close$0.12
52-week range$0.06 - $0.30
50-day moving average $0.10
200-day moving average $0.13
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.06

Is it a good time to buy Guided Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Guided Therapeutics price performance over time

Historical closes compared with the close of $0.12 from 2024-07-10

1 week (2024-07-05) -16.61%
1 month (2024-06-12) 9.09%
3 months (2024-04-08) N/A
6 months (2024-01-08) N/A
1 year (2023-07-08) N/A
2 years (2022-07-11) -76.00%
3 years (2021-07-09) 0.65
5 years (2019-07-11) 0.175

Guided Therapeutics financials

Revenue TTM $82,000
Gross profit TTM $-68,000
Return on assets TTM -84.73%
Return on equity TTM 0%
Profit margin 0%
Book value $-0.13
Market Capitalization $8 million

TTM: trailing 12 months

Guided Therapeutics share dividends

We're not expecting Guided Therapeutics to pay a dividend over the next 12 months.

You may also wish to consider:

Have Guided Therapeutics's shares ever split?

Guided Therapeutics's shares were split on a 1:800 basis on 28 March 2019. So if you had owned 800 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Guided Therapeutics shares – just the quantity. However, indirectly, the new 79900% higher share price could have impacted the market appetite for Guided Therapeutics shares which in turn could have impacted Guided Therapeutics's share price.

Guided Therapeutics share price volatility

Over the last 12 months, Guided Therapeutics's shares have ranged in value from as little as $0.064 up to $0.3. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Guided Therapeutics's is 0.497. This would suggest that Guided Therapeutics's shares are less volatile than average (for this exchange).

To put Guided Therapeutics's beta into context you can compare it against those of similar companies.

Guided Therapeutics overview

Guided Therapeutics, Inc. , a medical technology company, develops medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc.

Frequently asked questions

What percentage of Guided Therapeutics is owned by insiders or institutions?
Currently 43.742% of Guided Therapeutics shares are held by insiders and 7.333% by institutions.
How many people work for Guided Therapeutics?
Latest data suggests 4 work at Guided Therapeutics.
When does the fiscal year end for Guided Therapeutics?
Guided Therapeutics's fiscal year ends in December.
Where is Guided Therapeutics based?
Guided Therapeutics's address is: 5835 Peachtree Corners East, Norcross, GA, United States, 30092

More guides on Finder

Ask a Question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site